Midnight in Germany March 31st turned into April 1st, the nation officially enacted its new adult-use cannabis legalization policy. Adults aged 18 and above can now enjoy the freedoms granted by the first pillar of the CanG law.
Kai-Friedrich Niermann, a prominent attorney at KFN+ Law Office, emphasized the need for a paradigm shift in drug policy, putting an end to the ineffective prohibition approach of the past century.
While Germany isn’t the pioneer in national adult-use cannabis legalization, its policy change marks the most significant shift since the initiation of global cannabis prohibition many years ago. Here are the key provisions of Germany’s new cannabis law that both consumers and patients should be aware of.
Key Highlights of Germany’s Cannabis Law:
Narcotics De-listing
Germany has implemented the new law, it is removing cannabis from its Narcotics List, marking a significant policy change. This shift holds immense importance. This change will eliminate certain hurdles in the medical cannabis supply chain and streamline processes for pharmacies. It will also facilitate easier pursuit of cannabis research. With hopes that academic institutions will start receiving national and/or EU-provided funds for specific research projects.
In the past, the cultivation of medical cannabis in Germany followed a licensing procedure overseen. By the nation’s Federal Office for Drugs and Medical Devices which made final determinations on the quantity and price of domestically produced medical cannabis. Imports did not undergo the same process, granting a significant advantage to companies located outside of Germany. The new adult-use cannabis law in Germany is expected to provide a substantial boost to the domestic medical industry.
Personal Cultivation
In Germany, adults can now legally cultivate cannabis in their homes for personal use. The new law allows adults to grow up to three plants privately. This practice is common in other regions where it’s permitted and offers consumers an additional way to access cannabis besides traditional storefronts.
With this change, a surge in opportunities is expected for companies specializing in cultivation-related products and services. From seeds and grow lights to harvesting equipment and odor control, the market is set to expand rapidly. Additionally, cannabis seeds and clones are now legal in Germany for both citizens and non-citizens alike.
Personal Possession
Germany now allows adults to possess up to 25 grams of cannabis for personal use, with penalties for exceeding the limit considered administrative violations. A 2021 study by Heinrich Heine University Dusseldorf estimates annual savings of 1.05 billion euros from ending cannabis prohibition, including 313 million euros in judicial savings. This change reflects a global trend towards more lenient cannabis regulations.
Noncommercial Cannabis Clubs
Germany’s new law includes the provision for noncommercial cannabis clubs to operate, with an expected start date of July 1, 2024. These membership-based clubs will legally provide adult consumers with cannabis, subject to specific regulations. It is anticipated that seeds and clones will primarily come from these clubs once they are established.
The implementation of noncommercial clubs was a significant point of contention leading up to the final coalition agreement. As part of the compromise, the launch date for these clubs will be staggered. Following their introduction, noncommercial clubs are likely to become widespread across most of Germany.
Future Policy Modernizations
Germany recently marked a significant milestone in its legalization journey by passing the initial phase of cannabis legalization, commonly known as ‘the first pillar.’ The next phase, ‘the second pillar,’ will focus on launching expansive regional programs for adult cannabis use, akin to existing models in the Netherlands and Switzerland but on a larger scale. Advocates anticipate a heightened effort in the upcoming months to guarantee a smooth rollout of Germany’s legalization framework.
The practical implementation of the law and its potential amendments post-enforcement to align with governmental commitments pose intriguing questions. The evolving landscape in the following weeks holds particular importance for cultivation groups, prompting potential adjustments in their operational structures. As highlighted by Peter Homberg from Dentons, monitoring these developments closely is imperative for stakeholders.
Despite these advancements, achieving complete destigmatization and equitable legalization remains a distant goal. Stakeholders, encompassing consumers, activists, and industry players, must sustain their momentum towards this objective. Kai Friedrich Niermann from KFN+ Law Office emphasized the ongoing necessity for collective dedication to realizing a successful path towards destigmatization and fairness in legalization efforts.
Related on Weedly: Keep exploring the Weedly Glossary, our strain reviews, the Learn hub, our Canada coverage and our USA coverage.
Sources & further reading: For authoritative background see Project CBD, Health Canada, NIDA (US National Institute on Drug Abuse), the World Health Organization and Wikipedia.
How it compares to other countries
Germany’s legalization model is distinctive when set against other legal markets. Unlike Canada or many US states, which permit commercial retail sales, Germany chose a non-commercial approach built on home cultivation and nonprofit clubs, with no dispensaries. This most closely resembles Malta’s club-based system and reflects a public-health philosophy that prioritizes controlled access over a commercial industry. By legalizing as the EU’s largest economy, Germany reshaped the European conversation, giving other countries a major example of adult-use legalization that stops short of full commercialization — a middle path between prohibition and the open markets of North America.
The medical and industry dimension
Alongside recreational reform, Germany’s 2024 law eased medical cannabis access by reclassifying cannabis, simplifying prescribing for doctors and patients. Germany was already one of Europe’s largest medical cannabis markets, relying heavily on imports, and the reforms further boosted interest and access. This medical dimension, combined with the country’s size, makes Germany a central player in the European cannabis industry, attracting producers and investment. The recreational and medical strands together position Germany at the heart of Europe’s cannabis future, influencing both patient access and the broader industry across the continent.
Learn more
For a complete explanation of Germany’s rules — possession limits, the club system, public-consumption restrictions and medical access — see our in-depth guides to whether cannabis is legal in Germany and inside Germany’s cannabis clubs. Explore more on our International desk and the cannabis glossary. For background, see the overview of cannabis in Germany.
